Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in CALGB 50401 (Alliance)

Adverse events (AEs) from chronically administered oral agents treating hematologic malignancies may affect patients’ ability to tolerate treatment over time. Conventional toxicity tables emphasizing incidence of high grade AEs do not provide information on AE time profile or reflect continuous lowe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Lancet Haematol
Autori principali: Thanarajasingam, Gita, Leonard, John P., Witzig, Thomas E., Habermann, Thomas M., Blum, Kristie A., Bartlett, Nancy L., Flowers, Christopher R., Pitcher, Brandelyn N., Jung, Sin-Ho, Atherton, Pamela J., Tan, Angelina, Novotny, Paul J., Dueck, Amylou C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7457391/
https://ncbi.nlm.nih.gov/pubmed/32470440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3026(20)30067-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi